BSE filing, NSE: MAYUKH. Summary written from the filing by ALFA Finder's alert engine.
Sattva Sukun Lifecare Ltd: key numbers
- Share price
- ₹1.16
- Market cap
- ₹44.50 Cr
- Revenue (annual)
- ₹32.25 Cr
- Net profit (annual)
- ₹0.11 Cr
- P/E (TTM)
- -91.9×Sector 43.1×
- Promoter holding
- 3.65%-2.74% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sattva Sukun Lifecare Ltd
All →Sattva Sukun Lifecare Other Announcement
Tavexia Lifecare Ltd submitted its quarterly shareholding pattern report for the period ended September 30, 2026, in compliance with SEBI regulations.
Sattva Sukun Lifecare Acquisition Worth ₹67.19 Cr
Tavexia Lifecare will acquire a 60% stake in Meyonex Pharmaceuticals Limited for ₹67.19 Crore. This strategic investment aims to expand its pharmaceutical sector presence.
- Value
- ₹67.19 Cr
Sattva Sukun Lifecare Annual General Meeting
Tavexia Lifecare Limited concluded its 46th Annual General Meeting on September 30, 2026. Shareholders approved the financial statements, auditor appointment, related party transactions, and director re-appointment.
Sattva Sukun Lifecare Promoter Selling: ₹0.03 Cr
Promoter group entity Roshan Dealmark Private Limited sold 2,50,000 equity shares of Tavexia Lifecare Ltd via market sale.
- Value
- ₹0.03 Cr
- Promoter stake change
- -0.04%
Sattva Sukun Lifecare Promoter Selling: ₹0.08 Cr
Roshan Dealmark Private Limited (Promoter Group) sold 700,000 equity shares of Tavexia Lifecare Ltd via market sale on September 25, 2026.
- Value
- ₹0.08 Cr
- Promoter stake change
- -0.18%
Sattva Sukun Lifecare Promoter Selling: ₹0.02 Cr
Promoter Group entity, Roshan Dealmark Private Limited, sold 2,00,000 shares of Tavexia Lifecare Ltd in the open market, aggregating to ₹0.02 Crore.
- Value
- ₹0.02 Cr
- Promoter stake change
- -0.06%
Other board meeting date announcements
All →M M Forgings Board Meeting Date
MM Forgings scheduled its Q2 FY27 board meeting for 5 November 2026 to approve unaudited standalone and consolidated results for the quarter ended 30 September 2026.
Gujarat Terce Laboratories Board Meeting Date
Gujarat Terce Laboratories will hold a board meeting on November 5, 2026 to consider unaudited standalone results for September 2026. The trading window stays closed until November 7, 2026.
Gautam Gems Board Meeting Date
Gautam Gems Ltd scheduled a board meeting for 3 Nov 2026 to approve Q2 FY27 standalone results. No financial figures or other material decisions are disclosed in this advance intimation.
Gujjubhai Industries Board Meeting Date
Gujjubhai Industries has scheduled its Board meeting for 4 November 2026. The agenda includes approval of unaudited Q1 and H1 FY27 financial results.
The Hi-Tech Gears Board Meeting Date
The Hi-Tech Gears Ltd has scheduled a Board meeting on November 4, 2026 to approve un-audited Q1 and H1 FY27 results. No financial figures are disclosed.
Cranex Board Meeting Date
Cranex Ltd scheduled a board meeting for 5 Nov 2026 to consider Q2 FY27 financial results. No monetary figures or decisions are disclosed in this advance notice.